Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 10/2016

01-10-2016

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)

Auteurs: N. E. Carlozzi, S. G. Schilling, J.-S. Lai, J. S. Paulsen, E. A. Hahn, J. S. Perlmutter, C. A. Ross, N. R. Downing, A. L. Kratz, M. K. McCormack, M. A. Nance, K. A. Quaid, J. C. Stout, R. C. Gershon, R. E. Ready, J. A. Miner, S. K. Barton, S. L. Perlman, S. M. Rao, S. Frank, I. Shoulson, H. Marin, M. D. Geschwind, P. Dayalu, S. M. Goodnight, D. Cella

Gepubliceerd in: Quality of Life Research | Uitgave 10/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Huntington disease (HD) is a chronic, debilitating genetic disease that affects physical, emotional, cognitive, and social health. Existing patient-reported outcomes (PROs) of health-related quality of life (HRQOL) used in HD are neither comprehensive, nor do they adequately account for clinically meaningful changes in function. While new PROs examining HRQOL (i.e., Neuro-QoL—Quality of Life in Neurological Disorders and PROMIS—Patient-Reported Outcomes Measurement Information System) offer solutions to many of these shortcomings, they do not include HD-specific content, nor have they been validated in HD. HDQLIFE addresses this by validating 12 PROMIS/Neuro-QoL domains in individuals with HD and by using established PROMIS methodology to develop new, HD-specific content.

Methods

New item pools were developed using cognitive debriefing with individuals with HD, and expert, literacy, and translatability reviews. Existing item banks and new item pools were field tested in 536 individuals with prodromal, early-, or late-stage HD.

Results

Moderate to strong relationships between Neuro-QoL/PROMIS measures and generic self-report measures of HRQOL, and moderate relationships between Neuro-QoL/PROMIS and clinician-rated measures of similar constructs supported the validity of Neuro-QoL/PROMIS in individuals with HD. Exploratory and confirmatory factor analysis, item response theory, and differential item functioning analyses were utilized to develop new item banks for Chorea, Speech Difficulties, Swallowing Difficulties, and Concern with Death and Dying, with corresponding six-item short forms. A four-item short form was developed for Meaning and Purpose.

Conclusions

HDQLIFE encompasses both validated Neuro-QoL/PROMIS measures, as well as five new scales in order to provide a comprehensive assessment of HRQOL in HD.
Literatuur
1.
go back to reference The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983. CrossRef The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971–983. CrossRef
2.
go back to reference Ross, C. A., et al. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol, 10(4), 204–216. PubMedCrossRef Ross, C. A., et al. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol, 10(4), 204–216. PubMedCrossRef
3.
go back to reference Squitieri, F., et al. (2015). Epidemiology of Huntington disease: First post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89, 367–370. PubMedCrossRef Squitieri, F., et al. (2015). Epidemiology of Huntington disease: First post-HTT gene analysis of prevalence in Italy. Clinical Genetics, 89, 367–370. PubMedCrossRef
4.
go back to reference Evans, S. J. W., et al. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology, Neurosurgery and Psychiatry, 84(10), 1156–1160. PubMedPubMedCentralCrossRef Evans, S. J. W., et al. (2013). Prevalence of adult Huntington’s disease in the UK based on diagnoses recorded in general practice records. Journal of Neurology, Neurosurgery and Psychiatry, 84(10), 1156–1160. PubMedPubMedCentralCrossRef
5.
go back to reference Paulsen, J. S. (2010). Early detection of huntington disease. Future Neurology, 5(1), 85–104. CrossRef Paulsen, J. S. (2010). Early detection of huntington disease. Future Neurology, 5(1), 85–104. CrossRef
6.
go back to reference Ross, C. A., et al. (1997). Huntington disease and the related disorder, dentatorubral–pallidoluysian atrophy (DRPLA). Medicine (Baltimore), 76(5), 305–338. CrossRef Ross, C. A., et al. (1997). Huntington disease and the related disorder, dentatorubral–pallidoluysian atrophy (DRPLA). Medicine (Baltimore), 76(5), 305–338. CrossRef
7.
go back to reference Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in Oncology, 22(2 Suppl 3), 73–81. PubMed Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in Oncology, 22(2 Suppl 3), 73–81. PubMed
8.
go back to reference World Health Organization, W. (1946). Preamble to the constitution of the World Health Organization as adopted by the International Health Conference. In International health conference, New York. World Health Organization, W. (1946). Preamble to the constitution of the World Health Organization as adopted by the International Health Conference. In International health conference, New York.
9.
go back to reference Campbell, A. J., Converse, P. E., & Rodgers, W. L. (1976). The quality of American life: Perceptions, evaluations, and satisfactions. New York: Russell Sage Foundation. Campbell, A. J., Converse, P. E., & Rodgers, W. L. (1976). The quality of American life: Perceptions, evaluations, and satisfactions. New York: Russell Sage Foundation.
10.
go back to reference Patrick, D. L., & Erikson, P. (1988). What constitutes quality of life? Concepts and dimensions. Clinical Nutrition, 7(2), 53–63. Patrick, D. L., & Erikson, P. (1988). What constitutes quality of life? Concepts and dimensions. Clinical Nutrition, 7(2), 53–63.
11.
go back to reference Jankovic, J., & Roos, R. A. (2014). Chorea associated with Huntington’s disease: To treat or not to treat? Movement Disorders, 29(11), 1414–1418. PubMedCrossRef Jankovic, J., & Roos, R. A. (2014). Chorea associated with Huntington’s disease: To treat or not to treat? Movement Disorders, 29(11), 1414–1418. PubMedCrossRef
12.
go back to reference Peavy, G. M., et al. (2010). Cognitive and functional decline in Huntington’s disease: Dementia criteria revisited. Movement Disorders, 25(9), 1163–1169. PubMedPubMedCentralCrossRef Peavy, G. M., et al. (2010). Cognitive and functional decline in Huntington’s disease: Dementia criteria revisited. Movement Disorders, 25(9), 1163–1169. PubMedPubMedCentralCrossRef
13.
15.
go back to reference Tibben, A., et al. (1993). Presymptomatic DNA-testing for Huntington disease—Pretest attitudes and expectations of applicants and their partners in the Dutch program. American Journal of Medical Genetics, 48(1), 10–16. PubMedCrossRef Tibben, A., et al. (1993). Presymptomatic DNA-testing for Huntington disease—Pretest attitudes and expectations of applicants and their partners in the Dutch program. American Journal of Medical Genetics, 48(1), 10–16. PubMedCrossRef
16.
go back to reference Hocaoglu, M. B., Gaffan, E. A., & Ho, A. K. (2012). The Huntington’s disease health-related Quality of Life questionnaire (HDQoL): A disease-specific measure of health-related quality of life. Clinical Genetics, 81(2), 117–122. PubMedPubMedCentralCrossRef Hocaoglu, M. B., Gaffan, E. A., & Ho, A. K. (2012). The Huntington’s disease health-related Quality of Life questionnaire (HDQoL): A disease-specific measure of health-related quality of life. Clinical Genetics, 81(2), 117–122. PubMedPubMedCentralCrossRef
17.
go back to reference Paulsen, J. S., et al. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology, 110, 2–28. PubMedCrossRef Paulsen, J. S., et al. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology, 110, 2–28. PubMedCrossRef
18.
go back to reference Cella, D., et al. (2011). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, 92(Suppl 1), S28–S36. PubMedPubMedCentralCrossRef Cella, D., et al. (2011). The neurology quality of life measurement (Neuro-QOL) initiative. Archives of Physical Medicine and Rehabilitation, 92(Suppl 1), S28–S36. PubMedPubMedCentralCrossRef
19.
go back to reference Gershon, R. C., et al. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21(3), 475–486. PubMedCrossRef Gershon, R. C., et al. (2012). Neuro-QOL: Quality of life item banks for adults with neurological disorders: Item development and calibrations based upon clinical and general population testing. Quality of Life Research, 21(3), 475–486. PubMedCrossRef
20.
go back to reference Cella, D., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested in its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63, 1179–1194. PubMedPubMedCentralCrossRef Cella, D., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested in its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63, 1179–1194. PubMedPubMedCentralCrossRef
21.
go back to reference van der Linden, W. J., & Hambleton, R. K. (1997). Handbook of modern item response theory. New York: Springer. CrossRef van der Linden, W. J., & Hambleton, R. K. (1997). Handbook of modern item response theory. New York: Springer. CrossRef
22.
23.
go back to reference Choppin, B. (1981). Educational measurement and the item bank model. In C. Lacey & D. Lawton (Eds.), Issues in evaluation and accountability (pp. 204–221). London: Methuen. Choppin, B. (1981). Educational measurement and the item bank model. In C. Lacey & D. Lawton (Eds.), Issues in evaluation and accountability (pp. 204–221). London: Methuen.
24.
go back to reference Nance, M. A. (2007). Comprehensive care in Huntington’s disease: A physician’s perspective. Brain Research Bulletin, 72(2–3), 175–178. PubMedCrossRef Nance, M. A. (2007). Comprehensive care in Huntington’s disease: A physician’s perspective. Brain Research Bulletin, 72(2–3), 175–178. PubMedCrossRef
25.
go back to reference Lai, J. S., et al. (2011). How item banks and its applications can influence measurement practice in rehabilitation medicine: A PROMIS fatigue item bank example. Archives of Physical Medicine and Rehabilitation, 92(Supp 1), S20–S27. PubMedPubMedCentralCrossRef Lai, J. S., et al. (2011). How item banks and its applications can influence measurement practice in rehabilitation medicine: A PROMIS fatigue item bank example. Archives of Physical Medicine and Rehabilitation, 92(Supp 1), S20–S27. PubMedPubMedCentralCrossRef
26.
go back to reference Carlozzi, N. E., et al. (2016). New measures to capture end of life concerns in Huntington disease: Meaning and purpose and concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system). Quality of Life Research. doi: 10.​1007/​s11136-016-1354-y. Carlozzi, N. E., et al. (2016). New measures to capture end of life concerns in Huntington disease: Meaning and purpose and concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system). Quality of Life Research. doi: 10.​1007/​s11136-016-1354-y.
27.
go back to reference Carlozzi, N. E., et al. (2016). The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea. Quality of Life Research.. doi: 10.​1007/​s11136-016-1307-5. Carlozzi, N. E., et al. (2016). The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea. Quality of Life Research.. doi: 10.​1007/​s11136-016-1307-5.
28.
go back to reference Carlozzi, N. E., et al. (2016). HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Quality of Life Research. doi: 10.​1007/​s11136-016-1273-y. Carlozzi, N. E., et al. (2016). HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties. Quality of Life Research. doi: 10.​1007/​s11136-016-1273-y.
30.
go back to reference Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225. PubMedCrossRef Carlozzi, N. E., & Tulsky, D. S. (2013). Identification of health-related quality of life (HRQOL) issues relevant to individuals with Huntington disease. Journal of Health Psychology, 18(2), 212–225. PubMedCrossRef
31.
go back to reference Kisala, P., & Tulsky, D. (2010). Opportunities for CAT applications in medical rehabilitation: Development of targeted item banks. Journal of Applied Measurement, 11(3), 315–330. PubMed Kisala, P., & Tulsky, D. (2010). Opportunities for CAT applications in medical rehabilitation: Development of targeted item banks. Journal of Applied Measurement, 11(3), 315–330. PubMed
32.
go back to reference Tourangeau, R. (1984). Cognitive sciences and survey methods. In T. Jabine, et al. (Eds.), Cognitive Aspects of survey methodology: Building a bridge between disciplines (pp. 73–100). Washington, DC: National Academy Press. Tourangeau, R. (1984). Cognitive sciences and survey methods. In T. Jabine, et al. (Eds.), Cognitive Aspects of survey methodology: Building a bridge between disciplines (pp. 73–100). Washington, DC: National Academy Press.
33.
go back to reference MetaMetrics. (1995). The LEXILE framework for reading. Durham, NC: MetaMetrics Inc. MetaMetrics. (1995). The LEXILE framework for reading. Durham, NC: MetaMetrics Inc.
34.
go back to reference Shoulson, I., & Fahn, S. (1979). Huntington disease—Clinical care and evaluation. Neurology, 29(1), 1–3. PubMedCrossRef Shoulson, I., & Fahn, S. (1979). Huntington disease—Clinical care and evaluation. Neurology, 29(1), 1–3. PubMedCrossRef
35.
go back to reference Hanauer, D. A., et al. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300. PubMedPubMedCentralCrossRef Hanauer, D. A., et al. (2015). Supporting information retrieval from electronic health records: A report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). Journal of Biomedical Informatics, 55, 290–300. PubMedPubMedCentralCrossRef
36.
go back to reference Paulsen, J. S., et al. (2006). Preparing for preventive clinical trials: The predict-HD study. Archives of Neurology, 63(6), 883–890. PubMedCrossRef Paulsen, J. S., et al. (2006). Preparing for preventive clinical trials: The predict-HD study. Archives of Neurology, 63(6), 883–890. PubMedCrossRef
37.
go back to reference Paulsen, J. S., et al. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery and Psychiatry, 79(8), 874–880. PubMedCrossRef Paulsen, J. S., et al. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery and Psychiatry, 79(8), 874–880. PubMedCrossRef
38.
go back to reference Paulsen, J. S., et al. (2014). Clinical and biomarker changes in premanifest huntington disease show trial feasibility: A decade of the PREDICT-HD study. Frontiers in Aging Neuroscience, 6, 78. PubMedPubMedCentralCrossRef Paulsen, J. S., et al. (2014). Clinical and biomarker changes in premanifest huntington disease show trial feasibility: A decade of the PREDICT-HD study. Frontiers in Aging Neuroscience, 6, 78. PubMedPubMedCentralCrossRef
39.
go back to reference Huntington Study Group. (1996). Unified Huntington’s Disease Rating Scale: Reliability and consistency. Movement Disorders, 11(2), 136–142. CrossRef Huntington Study Group. (1996). Unified Huntington’s Disease Rating Scale: Reliability and consistency. Movement Disorders, 11(2), 136–142. CrossRef
40.
go back to reference Hogarth, P., et al. (2005). Interrater agreement in the assessment of motor manifestations of Huntington’s disease. Movement Disorders, 20(3), 293–297. PubMedCrossRef Hogarth, P., et al. (2005). Interrater agreement in the assessment of motor manifestations of Huntington’s disease. Movement Disorders, 20(3), 293–297. PubMedCrossRef
41.
go back to reference Huntington Study Group. (2006). Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology, 66(3), 366–372. CrossRef Huntington Study Group. (2006). Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology, 66(3), 366–372. CrossRef
42.
go back to reference Siesling, S., et al. (1998). Unified Huntington’s disease rating scale: A follow up. Movement Disorders, 13(6), 915–919. PubMedCrossRef Siesling, S., et al. (1998). Unified Huntington’s disease rating scale: A follow up. Movement Disorders, 13(6), 915–919. PubMedCrossRef
43.
go back to reference Tabrizi, S. J., et al. (2011). Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurology, 10(1), 31–42. PubMedCrossRef Tabrizi, S. J., et al. (2011). Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: The 12-month longitudinal analysis. Lancet Neurology, 10(1), 31–42. PubMedCrossRef
44.
go back to reference Busse, M., et al. (2011). Utilisation of Healthcare and Associated Services in Huntington’s disease: A data mining study. PLoS Currents, 3, RRN1206. PubMedPubMedCentralCrossRef Busse, M., et al. (2011). Utilisation of Healthcare and Associated Services in Huntington’s disease: A data mining study. PLoS Currents, 3, RRN1206. PubMedPubMedCentralCrossRef
45.
go back to reference Carlozzi, N. E., et al. (2014). Understanding the outcomes measures used in huntington disease pharmacological trials: A systematic review. Journal of Huntington’s Disease, 3(3), 233–252. PubMedPubMedCentral Carlozzi, N. E., et al. (2014). Understanding the outcomes measures used in huntington disease pharmacological trials: A systematic review. Journal of Huntington’s Disease, 3(3), 233–252. PubMedPubMedCentral
47.
go back to reference Smith, A. (1982). Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services. Smith, A. (1982). Symbol digit modalities test: Manual. Los Angeles: Western Psychological Services.
48.
go back to reference Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental- Psychology, Vol. 18, pp. 643–662, 1935). Journal of Experimental Psychology- General, 121(1): 15–23. Stroop, J. R. (1992). Studies of interference in serial verbal reactions (Reprinted from Journal Experimental- Psychology, Vol. 18, pp. 643–662, 1935). Journal of Experimental Psychology- General, 121(1): 15–23.
49.
go back to reference Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643–662. CrossRef Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643–662. CrossRef
50.
go back to reference Craufurd, D., Thompson, J. C., & Snowden, J. S. (2001). Behavioral changes in Huntington disease. Neuropsychiatry, Neuropsychology, & Behavioral Neurology, 14(4), 219–226. Craufurd, D., Thompson, J. C., & Snowden, J. S. (2001). Behavioral changes in Huntington disease. Neuropsychiatry, Neuropsychology, & Behavioral Neurology, 14(4), 219–226.
52.
go back to reference Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol group. Annals of Medicine, 33(5), 337–343. PubMedCrossRef Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol group. Annals of Medicine, 33(5), 337–343. PubMedCrossRef
53.
go back to reference Lord, F. M. (1980). Applications of item response theory to practical testing problems. Hillside, NJ: Erlbaum. Lord, F. M. (1980). Applications of item response theory to practical testing problems. Hillside, NJ: Erlbaum.
54.
go back to reference De Ayala, R. J. (2009). The theory and practice of item response theory. New York: The Guilford Press. De Ayala, R. J. (2009). The theory and practice of item response theory. New York: The Guilford Press.
56.
go back to reference Muthén, L. K., & Muthén, B. O. (2011). Mplus User’s Guide. Los Angeles, CA: Muthén & Muthén. Muthén, L. K., & Muthén, B. O. (2011). Mplus User’s Guide. Los Angeles, CA: Muthén & Muthén.
57.
go back to reference McDonald, R. P. (1999). Test theory: A unified treatment. Mahwah, NJ: Lawrence Erlbaum Associates Inc. McDonald, R. P. (1999). Test theory: A unified treatment. Mahwah, NJ: Lawrence Erlbaum Associates Inc.
58.
go back to reference Cook, K. F., Kallen, M. A., & Amtmann, D. (2009). Having a fit: Impact of number of items and distribution of data on traditional criteria for assessing IRT’s unidimensionality assumption. Quality of Life Research, 18(4), 447–460. PubMedPubMedCentralCrossRef Cook, K. F., Kallen, M. A., & Amtmann, D. (2009). Having a fit: Impact of number of items and distribution of data on traditional criteria for assessing IRT’s unidimensionality assumption. Quality of Life Research, 18(4), 447–460. PubMedPubMedCentralCrossRef
59.
go back to reference Reise, S. P., Morizot, J., & Hays, R. D. (2007). The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Quality of Life Research, 16(Suppl 1), 19–31. PubMedCrossRef Reise, S. P., Morizot, J., & Hays, R. D. (2007). The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Quality of Life Research, 16(Suppl 1), 19–31. PubMedCrossRef
60.
go back to reference Samejima, F., van der Liden, W. J., & Hambleton, R. (1996). The graded response model. In W. J. van der Liden (Ed.), Handbook of modern item response theory (pp. 85–100). NY: Springer. Samejima, F., van der Liden, W. J., & Hambleton, R. (1996). The graded response model. In W. J. van der Liden (Ed.), Handbook of modern item response theory (pp. 85–100). NY: Springer.
61.
go back to reference Cai, L., Thissen, D., & du Toit, S. H. C. (2011). IRTPRO for windows [Computer software]. 2011, Lincolnwood, IL: Scientific Software International. Cai, L., Thissen, D., & du Toit, S. H. C. (2011). IRTPRO for windows [Computer software]. 2011, Lincolnwood, IL: Scientific Software International.
62.
go back to reference R Core Team. (2014). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. R Core Team. (2014). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
63.
go back to reference Choi, S. W., Gibbons, L. E., & Crane, P. K. (2011). Lordif: An R package for detecting differential item functioning using iterative hybrid ordinal logistic regression/item response theory and monte carlo simulations. Journal of Statistical Software, 39(8), 1–30. PubMedPubMedCentralCrossRef Choi, S. W., Gibbons, L. E., & Crane, P. K. (2011). Lordif: An R package for detecting differential item functioning using iterative hybrid ordinal logistic regression/item response theory and monte carlo simulations. Journal of Statistical Software, 39(8), 1–30. PubMedPubMedCentralCrossRef
64.
go back to reference Ustun, T. B., et al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823. PubMedPubMedCentralCrossRef Ustun, T. B., et al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823. PubMedPubMedCentralCrossRef
65.
go back to reference Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). New York: Academic Press.
66.
go back to reference Samejima, F. (1969). Estimation of latent ability using a response pattern of graded scores (Psychometric Monograph No. 17). Richmond, VA: Psychometric Society. Samejima, F. (1969). Estimation of latent ability using a response pattern of graded scores (Psychometric Monograph No. 17). Richmond, VA: Psychometric Society.
67.
go back to reference Bryant, F. B., & Yarnold, P. R. (1995). Principal components analysis and exploratory and confirmatory factor analysis. In L. G. Grimm & R. R. Yarnold (Eds.), Reading and understanding multivariate statistics (pp. 99–136). Washington, DC: American Psychological Association. Bryant, F. B., & Yarnold, P. R. (1995). Principal components analysis and exploratory and confirmatory factor analysis. In L. G. Grimm & R. R. Yarnold (Eds.), Reading and understanding multivariate statistics (pp. 99–136). Washington, DC: American Psychological Association.
68.
go back to reference Everitt, B. S. (1975). Multivariate analysis: The need for data, and other problems. British Journal of Psychiatry, 126, 237–240. PubMedCrossRef Everitt, B. S. (1975). Multivariate analysis: The need for data, and other problems. British Journal of Psychiatry, 126, 237–240. PubMedCrossRef
69.
go back to reference Gorsuch, R. L., & Analysis, Factor. (1983). Hillsdale. NJ: Lawrence Erlbaum Associates. Gorsuch, R. L., & Analysis, Factor. (1983). Hillsdale. NJ: Lawrence Erlbaum Associates.
70.
go back to reference Clauser, B. E., & Hambleton, R. K. (1994). Review of differential item functioning, P. W. Holland, H. Wainer. Journal of Educational Measurement, 31(1), 88–92. CrossRef Clauser, B. E., & Hambleton, R. K. (1994). Review of differential item functioning, P. W. Holland, H. Wainer. Journal of Educational Measurement, 31(1), 88–92. CrossRef
71.
go back to reference Anastasi, A., & Urbina, S. (1997). Psychological testing (7th ed.). Upper Saddle River, NJ: Prentice Hall. Anastasi, A., & Urbina, S. (1997). Psychological testing (7th ed.). Upper Saddle River, NJ: Prentice Hall.
72.
go back to reference Tabrizi, S. J., et al. (2012). Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurology, 11(1), 42–53. PubMedCrossRef Tabrizi, S. J., et al. (2012). Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurology, 11(1), 42–53. PubMedCrossRef
74.
go back to reference Smith, K. M., & Dahodwala, N. (2014). Sex differences in Parkinson’s disease and other movement disorders. Experimental Neurology, 259, 44–56. PubMedCrossRef Smith, K. M., & Dahodwala, N. (2014). Sex differences in Parkinson’s disease and other movement disorders. Experimental Neurology, 259, 44–56. PubMedCrossRef
75.
go back to reference Tabrizi, S. J., et al. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurology, 8(9), 791–801. PubMedPubMedCentralCrossRef Tabrizi, S. J., et al. (2009). Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data. Lancet Neurology, 8(9), 791–801. PubMedPubMedCentralCrossRef
76.
go back to reference Paulsen, J. S., et al. (2014). Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study. Front Aging Neurosci, 6, 78. PubMedPubMedCentralCrossRef Paulsen, J. S., et al. (2014). Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: A decade of the PREDICT-HD study. Front Aging Neurosci, 6, 78. PubMedPubMedCentralCrossRef
77.
go back to reference Dunn, K. M., et al. (2004). Patterns of consent in epidemiologic research: Evidence from over 25,000 responders. American Journal of Epidemiology, 159(11), 1087–1094. PubMedCrossRef Dunn, K. M., et al. (2004). Patterns of consent in epidemiologic research: Evidence from over 25,000 responders. American Journal of Epidemiology, 159(11), 1087–1094. PubMedCrossRef
78.
go back to reference Burg, J. A., Allred, S. L., & Sapp, J. H, 2nd. (1997). The potential for bias due to attrition in the National Exposure Registry: An examination of reasons for nonresponse, nonrespondent characteristics, and the response rate. Toxicology and Industrial Health, 13(1), 1–13. PubMed Burg, J. A., Allred, S. L., & Sapp, J. H, 2nd. (1997). The potential for bias due to attrition in the National Exposure Registry: An examination of reasons for nonresponse, nonrespondent characteristics, and the response rate. Toxicology and Industrial Health, 13(1), 1–13. PubMed
79.
go back to reference Eagan, T. M., et al. (2002). Nonresponse in a community cohort study: Predictors and consequences for exposure-disease associations. Journal of Clinical Epidemiology, 55(8), 775–781. PubMedCrossRef Eagan, T. M., et al. (2002). Nonresponse in a community cohort study: Predictors and consequences for exposure-disease associations. Journal of Clinical Epidemiology, 55(8), 775–781. PubMedCrossRef
80.
go back to reference Haga, S. B., et al. (2013). Public knowledge of and attitudes toward genetics and genetic testing. Genetic Testing and Molecular Biomarkers, 17(4), 327–335. PubMedPubMedCentralCrossRef Haga, S. B., et al. (2013). Public knowledge of and attitudes toward genetics and genetic testing. Genetic Testing and Molecular Biomarkers, 17(4), 327–335. PubMedPubMedCentralCrossRef
81.
go back to reference Roberts, J. S., et al. (2004). Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine, 6(4), 197–203. PubMedCrossRef Roberts, J. S., et al. (2004). Who seeks genetic susceptibility testing for Alzheimer’s disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine, 6(4), 197–203. PubMedCrossRef
82.
go back to reference Huntington Study Group, P.I., et al. (2016). Clinical-genetic associations in the prospective Huntington at Risk Observational Study (PHAROS): Implications for clinical trials. JAMA Neurology, 73(1), 102–110. CrossRef Huntington Study Group, P.I., et al. (2016). Clinical-genetic associations in the prospective Huntington at Risk Observational Study (PHAROS): Implications for clinical trials. JAMA Neurology, 73(1), 102–110. CrossRef
83.
go back to reference Pringsheim, T., et al. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091. PubMedCrossRef Pringsheim, T., et al. (2012). The incidence and prevalence of Huntington’s disease: A systematic review and meta-analysis. Movement Disorders, 27(9), 1083–1091. PubMedCrossRef
84.
go back to reference Folstein, S. E. (1989). Huntington’s disease: A disorder of families. Baltimore: Johns Hopkins University Press. Folstein, S. E. (1989). Huntington’s disease: A disorder of families. Baltimore: Johns Hopkins University Press.
85.
go back to reference Hayden, M. R., MacGregor, J. M., & Beighton, P. H. (1980). The prevalence of Huntington’s chorea in South Africa. South African Medical Journal, 58, 193–196. PubMed Hayden, M. R., MacGregor, J. M., & Beighton, P. H. (1980). The prevalence of Huntington’s chorea in South Africa. South African Medical Journal, 58, 193–196. PubMed
86.
go back to reference Narabayashi, H. (1973). Huntington’s chorea in Japan: Review of the literature. Advances in Neurology, 1, 253–259. Narabayashi, H. (1973). Huntington’s chorea in Japan: Review of the literature. Advances in Neurology, 1, 253–259.
88.
go back to reference Rutherford, C., et al. (2016). Mode of administration does not cause bias in patient-reported outcome results: A meta-analysis. Quality of Life Research, 25(3), 559–574. PubMedCrossRef Rutherford, C., et al. (2016). Mode of administration does not cause bias in patient-reported outcome results: A meta-analysis. Quality of Life Research, 25(3), 559–574. PubMedCrossRef
89.
go back to reference Duff, K., et al. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: Evidence of early lack of awareness. Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207. PubMedPubMedCentralCrossRef Duff, K., et al. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: Evidence of early lack of awareness. Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 196–207. PubMedPubMedCentralCrossRef
90.
go back to reference Bull, M. T., et al. (2014). A pilot study of virtual visits in Huntington disease. Journal of Huntington’s Disease, 3(2), 189–195. PubMed Bull, M. T., et al. (2014). A pilot study of virtual visits in Huntington disease. Journal of Huntington’s Disease, 3(2), 189–195. PubMed
Metagegevens
Titel
HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)
Auteurs
N. E. Carlozzi
S. G. Schilling
J.-S. Lai
J. S. Paulsen
E. A. Hahn
J. S. Perlmutter
C. A. Ross
N. R. Downing
A. L. Kratz
M. K. McCormack
M. A. Nance
K. A. Quaid
J. C. Stout
R. C. Gershon
R. E. Ready
J. A. Miner
S. K. Barton
S. L. Perlman
S. M. Rao
S. Frank
I. Shoulson
H. Marin
M. D. Geschwind
P. Dayalu
S. M. Goodnight
D. Cella
Publicatiedatum
01-10-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1386-3

Andere artikelen Uitgave 10/2016

Quality of Life Research 10/2016 Naar de uitgave